Timely & critical insights across the spectrum of pharma & biotech

HomeCategory

Deals - PharmForward

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/08/Xywav-Gets-FDA-Approval-to-Treat-Idiopathic-Hypersomnia-in-Adults-640x480.jpg

Deals R & D, Regulatory & Policy

Jazz Pharma’s Xywav Gets FDA Approval for Idiopathic Hypersomnia in Adults

August 25, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/08/Lumen-Bioscience-Teams-with-Google-to-Apply-Machine-Learning-to-Biologics-Manufacturing-640x480.jpg

Deals R & D, Regulatory & Policy

Lumen Bioscience teams with Google to Apply ML to Biologics Manufacturing

August 17, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/08/Sanofi-to-acquire-Translate-Bio-in-USD-3.2-Bn-deal-to-push-mRNA-technology-640x480.jpg

Deals R & D, Regulatory & Policy

Sanofi to Acquire Translate Bio for USD 3.2 Bn to Expand m-RNA Platform Products

August 10, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/Intas-DongA-Meiji-640x480.jpg

Biosimilar Deals

Intas Acquires Global Rights for Stelara® Biosimilar

July 23, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/PF_IPSEN-640x480.jpg

Deals Patented Drugs & Vaccines

Ipsen Enters Exclusive Worldwide Licensing Agreement with IRLAB

July 21, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/BioNTech-purchases-Kites-discovery-platform-and-manufacturing-facility-1-640x480.jpg

Deals Regenerative & Cell Therapies

BioNTech purchases Kite’s discovery platform and manufacturing facility

July 20, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/08/Bayers-Kerendia-recieves-USFDA-approval-for-kidney-and-heart-disease-in-Type-2-diabetes-patients-640x480.jpg

Deals R & D, Regulatory & Policy

Bayer’s Kerendia receives USFDA approval for kidney and heart disease in Type 2 diabetes patients

July 16, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/novo-nordisk-prothena-640x480.jpg

Deals Patented Drugs & Vaccines

Novo Nordisk acquires ATTR Amyloidosis program for USD 1.2 Bn

July 14, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/06/Teva-Bioeq-640x480.jpg

Biosimilar Deals

Teva partners with Bioeq to commercialize Lucentis® Biosimilar

June 29, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/06/Novo-Holdings-640x480.jpg

Novo Holdings Acquires BBI Group For USD 550 Million

June 21, 20210